Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies clinical trial (NCT00649584). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from SGN-35 and gemcitabine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies clinical trial (NCT00649584). Contact the study team or your healthcare provider for specific answers.

Question 3

How often would I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies clinical trial (NCT00649584). Contact the study team or your healthcare provider for specific answers.

Question 4

What does the process of dose escalation mean for my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies clinical trial (NCT00649584). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with combining SGN-35 and gemcitabine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies clinical trial (NCT00649584). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies clinical trial (NCT00649584). Contact the study team or your healthcare provider for specific answers.

What this study is about